NCT07627919

Brief Summary

Sixty obese elderly women will be recruited from Fawkia hospital outpatient clinic diagnosed by sarcopenia and randomly allocated into two groups for a 12-week intervention. Patients will be divided into 2 groups (A and B):

  • Group A (combined intervention group: n=30): will perform supervised resistance exercise training three times per week and follow a high-protein diet (1.3 g protein/kg/day)
  • Group B (control group: n=30): will receive a high-protein diet and general health advices and be asked to maintain their usual lifestyle. They will be offered the intervention post-study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
17mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Jun 2026Dec 2027

First Submitted

Initial submission to the registry

May 30, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 4, 2026

Completed
26 days until next milestone

Study Start

First participant enrolled

June 30, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2027

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2027

Last Updated

June 4, 2026

Status Verified

May 1, 2026

Enrollment Period

11 months

First QC Date

May 30, 2026

Last Update Submit

May 30, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • balance assessment

    The Biodex Balance System SD features five test protocols and six training modes, allowing for both testing and training in either static or dynamic formats. It is intended to be a system that can provide accurate Fall Risk Screening and conditioning for older adults, can be used as a balance assessment tool for concussion management, and can serve as weight-bearing assessment and training for lower extremity injuries.

    12 weeks

Secondary Outcomes (6)

  • Health-Related Quality of Life

    12 weeks

  • hallmarks of sarcopenia

    12 weeks

  • Muscle quality index

    12 weeks

  • Handgrip strength assessment

    12 weeks

  • Waist-to-hip ratio assessment

    12 weeks

  • +1 more secondary outcomes

Study Arms (2)

Group A (combined intervention group)

EXPERIMENTAL

Group A (combined intervention group: n=30): will perform supervised resistance exercise training three times per week and follow a high -protein diet (1.3 g protein/kg/day)

Other: supervised resistance exercise training and aOther: high -protein diet

Group B (control group)

ACTIVE COMPARATOR

Group B (control group: n=30): will receive high protein diet and general health advices and be asked to maintain their usual lifestyle. They will be offered the intervention post-study.

Other: high -protein diet

Interventions

supervised resistance exercise training three times per week

Group A (combined intervention group)

a high-protein diet (1.3 g protein/kg/day)

Group A (combined intervention group)Group B (control group)

Eligibility Criteria

Age60 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \) Female gender 2) Age 60-70 years 3) BMI ≥ 30 kg/m2 4) Sarcopenic patients diagnosed by their physicians according to EWGSOP2 criteria (low muscle strength confirmed by handgrip strength or chair stand test, plus low muscle quantity confirmed by BIA or DXA), and SARC-F score \>3.
  • \) Ambulatory and able to participate in exercise. 6) Stable medical condition. 7) The patients didn't follow any type of diet before the treatment at least 4 weeks ago.
  • \) Patients didn't follow any exercise program before treatment at least 4 weeks ago.

You may not qualify if:

  • \) Sever cardiovascular, pulmonary, renal, or hepatic disease. 2) Uncontrolled diabetes or hypertension. 3) Neurological or musculoskeletal disorders prohibiting exercise 4) Cancer or other terminal illness. 5) Current use of anti-inflammatory drugs or steroids. 6) Metal implants prohibiting BIA assessment. 7) Cognitive impairment impairing ability to consent or follow instructions. 8) Using drugs that would affect metabolism or balance. 9) Using assistive devices for walking.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fawkia hospital outpatient clinic

El-Sheikh Zayed City, Egypt

RECRUITING

MeSH Terms

Conditions

Obesity

Interventions

Diet, High-Protein

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • shaimaa elsayed, master

    Physical Therapy for Cardiovascular/Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Shaimaa Elsayed, master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

May 30, 2026

First Posted

June 4, 2026

Study Start

June 30, 2026

Primary Completion (Estimated)

May 30, 2027

Study Completion (Estimated)

December 30, 2027

Last Updated

June 4, 2026

Record last verified: 2026-05

Locations